Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V T Devita

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 1991
Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPPD L Longo, P L Duffey, V T DeVita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 1991
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trialD L Longo, V T DeVita, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapyD L Longo, E Glatstein, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1992
Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cureD L Longo, P L Duffey, R C Young, et al.
The British Journal of Cancer. Supplement|March 1, 1975
Percutaneous liver biopsy, peritoneoscopy and laparotomy: an assessment of relative merits in the lymphomataB A Chabner, R E Johnson, P B Chretien, et al.
Annals of Internal Medicine|March 1, 1979
Whole body hyperthermia: a phase-I trial of a potential adjuvant to chemotherapyJ M Bull, D Lees, W Schuette, et al.
Cancer Journal (Sudbury, Mass.)|November 18, 2000
A phase I study of the antimetabolite (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731) administered as a twice-weekly infusionB Burtness, M Belker, M Stoltz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's diseaseD L Longo, E Glatstein, P L Duffey, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 1991
Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPPD L Longo, P L Duffey, V T DeVita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 1991
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trialD L Longo, V T DeVita, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapyD L Longo, E Glatstein, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1992
Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cureD L Longo, P L Duffey, R C Young, et al.
The British Journal of Cancer. Supplement|March 1, 1975
Percutaneous liver biopsy, peritoneoscopy and laparotomy: an assessment of relative merits in the lymphomataB A Chabner, R E Johnson, P B Chretien, et al.
Annals of Internal Medicine|March 1, 1979
Whole body hyperthermia: a phase-I trial of a potential adjuvant to chemotherapyJ M Bull, D Lees, W Schuette, et al.
Cancer Journal (Sudbury, Mass.)|November 18, 2000
A phase I study of the antimetabolite (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731) administered as a twice-weekly infusionB Burtness, M Belker, M Stoltz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's diseaseD L Longo, E Glatstein, P L Duffey, et al.
Pageof 13